LaBelforte launches business entities for Covid-19 nasal products development
The intranasal/inhalation products, which boost mucosal immunity, may advance the control of the disease.
Drug Development
Latest in
Drug Development
UCB to buy rare disease therapies developer Zogenix for $1.9bn
The company’s subsidiary will be merged into Zogenix and the remaining shares of Zogenix common stock will be cancelled.
Australian TGA grants approval to two oral medicines for Covid-19
The medications are the first oral treatments for Covid-19 to be approved in the country.
GSK’s top scientist to quit, become CEO of anti-ageing start-up
GSK’s chief scientific officer, Hal Barron, will head up the Silicon Valley biotech Altos Labs.
By
Moderna eyes combined Covid-19, flu booster by 2023
Moderna CEO Stéphane Bancel also said an Omicron-specific Covid-19 vaccine will enter clinical development in a matter of weeks.
By
Covid-19 update: Fourth shot of vaccine can’t prevent Omicron infections
Global: The global Covid death toll has passed the grim milestone of 5.5 million, with a figure of 5,545,923 according…
Medlab receives grant to develop NanoCelle nasal vaccine for Covid-19
The company will collaborate with the University of NSW and Macquarie University for vaccine development.
Restrictive Medicare coverage spells continued uncertainty for Aduhelm
Despite Aduhelm’s first-to-market advantage, months of controversy following the drug’s approval have been a major setback.
By